(MedPage Today) — A new analysis showed children whose fathers were treated with valproate during spermatogenesis had no increased risk of neurodevelopmental disorders, contrary to IQVIA data used to support a 2024 European Medicines Agency warning…
Source link : https://www.medpagetoday.com/neurology/generalneurology/115763
Author :
Publish date : 2025-05-27 16:02:00
Copyright for syndicated content belongs to the linked Source.
